Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Bonnetain

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|September 20, 2012
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO studyAziz Zaanan, Nicolas Williet, Mohamed Hebbar, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2012
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patientsClaire Schvartz, Franck Bonnetain, Sandrine Dabakuyo, et al.
BMJ Open|June 26, 2016
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinomaAmélie Anota, Mathieu Boulin, Sandrine Dabakuyo-Yonli, et al.
BMC Geriatrics|November 19, 2016
Development and validation of the FRAGIRE tool for assessment an older person's risk for frailtyDewi Vernerey, Amelie Anota, Pierre Vandel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinomaJean-Claude Barbare, Olivier Bouché, Franck Bonnetain, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR studyMohamed Hebbar, Benoist Chibaudel, Thierry André, et al.
Journal of Hepatology|November 5, 2010
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative settingCaroline Tournoux-Facon, Xavier Paoletti, Jean-Claude Barbare, et al.
Resuscitation|February 17, 2017
Predictors of long-term functional outcome and health-related quality of life after out-of-hospital cardiac arrestGuillaume Geri, Florence Dumas, Franck Bonnetain, et al.
Gastroenterologie Clinique Et Biologique|March 1, 2006
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncologyFranck Bonnetain, Olivier Bouché, Thierry Conroy, et al.
Health and Quality of Life Outcomes|February 6, 2019
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocolGuillaume Mouillet, Joëlle Fritzsch, Sophie Paget-Bailly, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|September 20, 2012
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO studyAziz Zaanan, Nicolas Williet, Mohamed Hebbar, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2012
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patientsClaire Schvartz, Franck Bonnetain, Sandrine Dabakuyo, et al.
BMJ Open|June 26, 2016
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinomaAmélie Anota, Mathieu Boulin, Sandrine Dabakuyo-Yonli, et al.
BMC Geriatrics|November 19, 2016
Development and validation of the FRAGIRE tool for assessment an older person's risk for frailtyDewi Vernerey, Amelie Anota, Pierre Vandel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinomaJean-Claude Barbare, Olivier Bouché, Franck Bonnetain, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR studyMohamed Hebbar, Benoist Chibaudel, Thierry André, et al.
Journal of Hepatology|November 5, 2010
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative settingCaroline Tournoux-Facon, Xavier Paoletti, Jean-Claude Barbare, et al.
Resuscitation|February 17, 2017
Predictors of long-term functional outcome and health-related quality of life after out-of-hospital cardiac arrestGuillaume Geri, Florence Dumas, Franck Bonnetain, et al.
Gastroenterologie Clinique Et Biologique|March 1, 2006
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncologyFranck Bonnetain, Olivier Bouché, Thierry Conroy, et al.
Health and Quality of Life Outcomes|February 6, 2019
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocolGuillaume Mouillet, Joëlle Fritzsch, Sophie Paget-Bailly, et al.
Pageof 17